Narcolepsy as an immune-associated hypothalamic encephalopathy: orexin dysfunction and implications for precision...

Area of Science:

• Neuroscience
• Immunology
• Sleep Medicine

Background:

• Narcolepsy is increasingly viewed as a multisystem hypothalamic disorder due to orexin neuron dysfunction.
• Evidence suggests narcolepsy type 1 aligns with immune-mediated neurological diseases, challenging traditional classifications.
• Existing diagnostic criteria based on cataplexy and sleep studies have limitations.

Purpose of the Study:

• To synthesize current evidence on narcolepsy's epidemiology, pathophysiology, diagnosis, and therapy.
• To propose a new framework for understanding narcolepsy beyond categorical diagnoses.
• To advocate for mechanism-based interventions and a spectrum-based approach.

Main Methods:

• Comprehensive literature review of PubMed, Web of Science, and Scopus (up to December 2025).
• Synthesis of genetic, neuropathological, immunological, and clinical data.
• Development of an integrative clinical algorithm based on phenotype, biomarkers, and mechanisms.

Main Results:

• Narcolepsy involves selective loss/dysfunction of orexin neurons, impacting motor, psychiatric, metabolic, and autonomic functions.
• Narcolepsy type 1 shares characteristics with immune-mediated neurological diseases.
• A spectrum-based framework and phenotype-biomarker-mechanism stratification are supported.

Conclusions:

• Narcolepsy requires a paradigm shift from a sleep disorder to a model of hypothalamic circuit vulnerability.
• Future treatments should focus on underlying mechanisms, including orexin agonism and immune-targeted strategies.
• An integrative diagnostic approach is crucial for advancing narcolepsy care.